| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14.2M | — |
| SG&A Expense | $13.6M | — |
| Operating Income | $73.0M | — |
| Pre-tax Income | $42.0M | — |
| Income Tax | $0 | — |
| Net Income | $42.0M | — |
| EPS (Basic) | $77.74 | — |
| EPS (Diluted) | $72.93 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13K | -99.7% |
| Current Assets | $1.6M | -74.4% |
| Total Assets | $3.1M | -54.1% |
| Current Liabilities | $14.1M | +8.4% |
| Total Liabilities | $31.7M | -80.2% |
| Stockholders' Equity | -$28.6M | +81.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.3M | — |
| Financing Cash Flow | $15.1M | — |